Literature DB >> 24670744

Immunology: A tolerant approach.

Ken Garber.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24670744     DOI： 10.1038/507418a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.

Authors:  B Bielekova; B Goodwin; N Richert; I Cortese; T Kondo; G Afshar; B Gran; J Eaton; J Antel; J A Frank; H F McFarland; R Martin
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

2.  Immune regulation of multiple sclerosis by transdermally applied myelin peptides.

Authors:  Maciej Juryńczyk; Agata Walczak; Anna Jurewicz; Dorota Jesionek-Kupnicka; Marian Szczepanik; Krzysztof Selmaj
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

3.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.

Authors:  Ganesh Suntharalingam; Meghan R Perry; Stephen Ward; Stephen J Brett; Andrew Castello-Cortes; Michael D Brunner; Nicki Panoskaltsis
Journal:  N Engl J Med       Date:  2006-08-14       Impact factor: 91.245

4.  Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.

Authors:  Bart O Roep; Nanette Solvason; Peter A Gottlieb; Joana R F Abreu; Leonard C Harrison; George S Eisenbarth; Liping Yu; Michael Leviten; William A Hagopian; John B Buse; Matthias von Herrath; Joanne Quan; Robert S King; William H Robinson; Paul J Utz; Hideki Garren; Lawrence Steinman
Journal:  Sci Transl Med       Date:  2013-06-26       Impact factor: 17.956

5.  Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.

Authors:  Daniel R Getts; Danielle M Turley; Cassandra E Smith; Christopher T Harp; Derrick McCarthy; Emma M Feeney; Meghann Teague Getts; Aaron J Martin; Xunrong Luo; Rachael L Terry; Nicholas J C King; Stephen D Miller
Journal:  J Immunol       Date:  2011-08-05       Impact factor: 5.422

6.  Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis.

Authors:  Andreas Lutterotti; Sara Yousef; Andreas Sputtek; Klarissa H Stürner; Jan-Patrick Stellmann; Petra Breiden; Stefanie Reinhardt; Christian Schulze; Maxim Bester; Christoph Heesen; Sven Schippling; Stephen D Miller; Mireia Sospedra; Roland Martin
Journal:  Sci Transl Med       Date:  2013-06-05       Impact factor: 17.956

7.  Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.

Authors:  Daniel R Getts; Aaron J Martin; Derrick P McCarthy; Rachael L Terry; Zoe N Hunter; Woon Teck Yap; Meghann Teague Getts; Michael Pleiss; Xunrong Luo; Nicholas J C King; Lonnie D Shea; Stephen D Miller
Journal:  Nat Biotechnol       Date:  2012-11-18       Impact factor: 54.908

8.  A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

Authors:  M S Freedman; A Bar-Or; J Oger; A Traboulsee; D Patry; C Young; T Olsson; D Li; H-P Hartung; M Krantz; L Ferenczi; T Verco
Journal:  Neurology       Date:  2011-10-05       Impact factor: 9.910

9.  Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.

Authors:  Leona Gabrysová; Kirsty S Nicolson; Heather B Streeter; Johan Verhagen; Catherine A Sabatos-Peyton; David J Morgan; David C Wraith
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

10.  Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.

Authors:  B L McRae; C L Vanderlugt; M C Dal Canto; S D Miller
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307
View more
  12 in total

1.  IDO1 and TGF-β Mediate Protective Effects of IFN-α in Antigen-Induced Arthritis.

Authors:  Jaya Prakash Chalise; Maria Teresa Pallotta; Sudeep Chenna Narendra; Björn Carlsson; Alberta Iacono; Joanitah Namale; Louis Boon; Ursula Grohmann; Mattias Magnusson
Journal:  J Immunol       Date:  2016-09-19       Impact factor: 5.422

Review 2.  Immune interventions to preserve β cell function in type 1 diabetes.

Authors:  Mario R Ehlers
Journal:  J Investig Med       Date:  2016-01       Impact factor: 2.895

3.  Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.

Authors:  Heather B Streeter; Rachel Rigden; Keith F Martin; Neil J Scolding; David C Wraith
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-03-12

4.  MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunity.

Authors:  Richard S Nicholas; Vassiliki Kostadima; Maya Hanspal; Benjamin R Wakerley; Ruhena Sergeant; Saskia Decuypere; Omar Malik; Rosemary J Boyton; Daniel M Altmann
Journal:  BMC Neurol       Date:  2015-05-03       Impact factor: 2.474

5.  Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy.

Authors:  Bronwen R Burton; Graham J Britton; Hai Fang; Johan Verhagen; Ben Smithers; Catherine A Sabatos-Peyton; Laura J Carney; Julian Gough; Stephan Strobel; David C Wraith
Journal:  Nat Commun       Date:  2014-09-03       Impact factor: 14.919

6.  A Novel Approach to Reinstating Tolerance in Experimental Autoimmune Myasthenia Gravis Using a Targeted Fusion Protein, mCTA1-T146.

Authors:  Alessandra Consonni; Sapna Sharma; Karin Schön; Cristina Lebrero-Fernández; Elena Rinaldi; Nils Yngve Lycke; Fulvio Baggi
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

Review 7.  Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective.

Authors:  Anja Ten Brinke; Marc Martinez-Llordella; Nathalie Cools; Catharien M U Hilkens; S Marieke van Ham; Birgit Sawitzki; Edward K Geissler; Giovanna Lombardi; Piotr Trzonkowski; Eva Martinez-Caceres
Journal:  Front Immunol       Date:  2019-02-22       Impact factor: 7.561

Review 8.  Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.

Authors:  Martin Ungerer; Julia Faßbender; Zhongmin Li; Götz Münch; Hans-Peter Holthoff
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

9.  ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs.

Authors:  Adriano Luís Soares De Souza; Stefan Rudin; Rui Chang; Keith Mitchell; Timothy Crandall; Shuning Huang; Ji-Kyung Choi; Shinji L Okitsu; Danielle L Graham; Blake Tomkinson; Tammy Dellovade
Journal:  Neurol Ther       Date:  2018-03-14

10.  A Sensitive Method for Detecting Peptide-specific CD4+ T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis.

Authors:  Sapna Sharma; Clas Malmeström; Christopher Lindberg; Sarah Meisel; Karin Schön; Martina Verolin; Nils Yngve Lycke
Journal:  Front Immunol       Date:  2017-10-24       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.